Skip to main content
logo
Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
40.66
+1.13 (2.86%)
Aug 3, 2026, 3:00 PM EDT - Market open

GRDN Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,4561,4491,2281,046908.91792.07
Revenue Growth
13.54%17.93%17.42%15.10%14.75%7.63%
Gross Profit
304.68292.72244.37208.31185.87161.27
Operating Income
12.5872.7-62.9240.9551.9930.15
Net Income
9.0349.22-110.05035.4216.31
Earnings Per Share
0.830.78-1.77-354210.00163140.00
EPS Growth
1188.08%---117.12%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
64.8965.624.660.750.6115.01
Total Debt
36.8937.1430.136156.8150.43
Net Cash (Debt)
28.0128.48-25.47-60.25-56.21-35.41
Net Cash Growth
------
Net Cash Per Share
0.440.45-0.41-602490.00-562070.00-354140.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
88.77100.2657.9670.8248.5258.5
Capital Expenditures
-18.76-19.55-16.37-14.56-16.77-9.28
Free Cash Flow
70.0180.7141.5956.2631.7549.22
Free Cash Flow Growth
44.72%94.05%-26.08%77.20%-35.48%11.17%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
20.93%20.21%19.89%19.91%20.45%20.36%
Operating Margin
0.86%5.02%-5.12%3.91%5.72%3.81%
Pretax Margin
0.86%5.07%-5.41%3.61%5.46%3.58%
Profit Margin
0.61%3.38%-5.78%3.61%5.46%3.58%
FCF Margin
4.81%5.57%3.39%5.38%3.49%6.21%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
48.6738.58----
Forward PE
32.2429.0024.31---
P/FCF Ratio
36.8623.6130.83---
PS Ratio
1.771.321.04---